Do I need a Coeliac, Tissue Transglutaminase Antibodies test?

Do you experience ongoing digestive discomfort, bloating, or fatigue that hasn't improved despite eating well? If coeliac disease is on your radar—whether you've noticed symptoms or have a family history—understanding your tissue transglutaminase antibody levels can help clarify what's happening in your body.

This biomarker measures immune proteins your body produces when gluten triggers an autoimmune response in your small intestine, causing inflammation and affecting nutrient absorption.

Knowing your tTG antibody status can empower you to understand whether gluten is activating your immune system and help guide conversations with your healthcare provider about next steps. It's one of the most sensitive and specific markers available, and it's included in Listen Health's autoimmunity screening panel so you can get a clearer picture of your health.

Coeliac, Tissue Transglutaminase Antibodies — Key Facts
MeasuresOne of the most sensitive and specific markers for coeliac disease.
CategoryAutoimmunity
Tested inListen Health Standard & Premium membership (100+ biomarkers)
Reviewed byDr Jamie Deans, MBChB

What is it?

Tissue transglutaminase (tTG) antibodies are immune proteins your body produces when it mistakenly sees gluten — a protein found in wheat, rye, and barley — as a threat. Under normal circumstances, tTG is an enzyme in your small intestine that helps repair tissue and process gluten fragments. However, in people with coeliac disease, gluten is modified by tTG in a way that triggers the immune system to attack both the gluten fragments and the tTG enzyme itself. This creates inflammation and damage along the small intestinal lining, especially the villi—tiny, finger-like projections responsible for absorbing nutrients.

There are two main antibody types measured:

  • tTG-IgA: The preferred and most accurate screening test for coeliac disease.

  • tTG-IgG: Used when someone has IgA deficiency, which can make the IgA version less reliable.

When these antibodies are elevated, it suggests that gluten exposure is activating the immune system and causing intestinal injury. Testing is most accurate when a person is still eating gluten, as antibodies decline when gluten is eliminated from the diet.

Book Your Test Now

Test Coeliac, Tissue Transglutaminase Antibodies as part of 100+ biomarkers with Listen Health's annual membership.

Start Testing Today
Developed by leading doctorsNo waiting, no referrals2,000+ locations Australia-wide

Why does it matter?

tTG antibodies are among the most sensitive and specific indicators of coeliac disease, with accuracy rates approaching 94% sensitivity and 97% specificity. This makes them a powerful tool for identifying whether your immune system is mounting an abnormal response to gluten.

Why this matters

Coeliac disease is not simply a digestive issue. It is an autoimmune condition that can significantly affect nutrient absorption and long-term health if left untreated. When the intestinal lining is damaged, your body’s capacity to absorb essential nutrients — including iron, folate, calcium, vitamin D, and B12 — is reduced. This can lead to fatigue, anemia, hair loss, weakened bones, infertility, mood changes, and neurological symptoms.

Persistent inflammation caused by ongoing gluten exposure may also increase the risk of other autoimmune diseases, such as autoimmune thyroid disease or autoimmune liver conditions. In children and adults, untreated coeliac disease may contribute to growth delays, hormone imbalances, and increased risk of certain cancers over the long term.

Monitoring tTG antibodies is also critical after diagnosis. When someone adopts a strict gluten-free diet, antibody levels should gradually fall over 6–12 months. Falling numbers indicate healing and good dietary adherence; persistently elevated results can mean hidden gluten exposure, cross-contamination, or slow intestinal recovery. Tracking these markers helps ensure your treatment plan is effective and supports long-term health and wellbeing.

What causes fluctuations?

Dietary factors

tTG antibody levels are directly influenced by gluten exposure. Eating foods containing wheat, rye, or barley — even in very small amounts — can cause levels to rise. Examples include bread, cereals, pasta, soy sauce, salad dressings thickened with wheat, malt-based products, and foods processed on shared lines that lead to cross-contamination. Once gluten is strictly removed from the diet, antibody levels gradually fall.

Duration of exposure

The longer someone consumes gluten while having coeliac disease, the more strongly the immune system responds, and the higher the antibody levels tend to be.

Intestinal healing

As inflammation settles and the lining repairs, tTG antibodies naturally decrease. Healing can take months to years depending on age, nutritional status, and strictness of gluten avoidance.

IgA deficiency

People with IgA deficiency may show normal tTG-IgA levels despite active coeliac disease. In this case, the IgG-based test becomes more accurate.

Testing timing

If someone is already gluten-free before testing, antibody levels may appear normal. This can mask underlying coeliac disease susceptibility, which is why gluten should not be removed until testing is complete.

Recommendations

Elevated tTG antibodies suggest your immune system is reacting to gluten.

Diet

  • Continue consuming gluten until all diagnostic testing is complete unless your clinician advises otherwise, to avoid false-negative results.

  • Once coeliac disease is confirmed, transition to a strict gluten-free diet with professional guidance.

  • Prioritise whole foods such as quinoa, buckwheat, millet, sorghum, legumes, nuts, vegetables, seafood, and certified gluten-free oats.

  • Replace refined gluten-free packaged foods with wholefoods to support gut healing and prevent nutrient gaps.

Lifestyle

  • Focus on reducing gut inflammation by including daily fibre from vegetables, nuts, seeds, and gluten-free whole grains.

  • Support recovery with consistent sleep and stress reduction practices, which help modulate immune activity.

What grains are gluten-free?

For individuals with coeliac disease or gluten intolerance, some grains are significantly better choices than others. The cornerstone of management is a lifelong, strict gluten-free diet that excludes wheat, rye, and barley. Fortunately, a number of gluten-free grains and pseudo-cereals — such as quinoa, amaranth, buckwheat, millet, and sorghum — offer excellent nutritional value. These grains are naturally rich in protein, fibre, B-complex vitamins, minerals, and healthy unsaturated fats, helping to improve the nutrient density of a gluten-free diet and support overall gut and metabolic health.

Pure, uncontaminated oats are also well tolerated by most people with coeliac disease and can contribute valuable fibre and micronutrients. It is, however, essential to confirm that oats are certified gluten-free to avoid cross-contamination during processing, which is a common source of inadvertent gluten exposure.

When selecting gluten-free foods, whole-grain and minimally processed options should always take priority. Many processed gluten-free products have a higher glycaemic index and lower nutritional quality compared with their whole-food counterparts. To counter common nutrient shortfalls associated with gluten-free diets—particularly fibre, iron, calcium, magnesium, and B-vitamins—it’s best to include a variety of whole gluten-free grains, legumes, nuts, seeds, leafy greens, seafood, and fortified foods.

For everyday practical use, choose certified gluten-free flours and grains, carefully read labels for “may contain gluten” or shared-line warnings, and rotate your grain choices to keep the diet diverse and nutritionally complete. Dishes such as quinoa bowls, buckwheat soba, millet pilafs, and sorghum porridges are simple ways to incorporate variety. If symptoms persist despite dietary vigilance, clinicians may recommend repeating laboratory tests—such as iron studies, vitamin B12 and folate, vitamin D, calcium, or follow-up coeliac serology—to check for hidden deficiencies or ongoing inflammation.

References

  1. Fasano, A., & Catassi, C. (2012). Celiac disease. The New England Journal of Medicine, 367(25), 2419–2426. https://doi.org/10.1056/NEJMcp1113994

  2. Hill, I. D., Fasano, A., Guandalini, S., et al. (2016). NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders. Journal of Pediatric Gastroenterology and Nutrition, 63(1), 156–165. https://doi.org/10.1097/MPG.0000000000001216

  3. Husby, S., Murray, J. A., & Katzka, D. A. (2019). AGA clinical practice update on diagnosis and monitoring of celiac disease—Changing utility of serology and histologic measures: Expert review. Gastroenterology, 156(4), 885–889. https://doi.org/10.1053/j.gastro.2018.12.010

  4. Rauhavirta, T., Hietikko, M., Salmi, T., & Lindfors, K. (2019). Transglutaminase 2 and transglutaminase 2 autoantibodies in celiac disease: A review. Clinical Reviews in Allergy & Immunology, 57(1), 23–38. https://doi.org/10.1007/s12016-016-8557-4

  5. Elli, L., Leffler, D., Cellier, C., et al. (2024). Guidelines for best practices in monitoring established coeliac disease in adult patients. Nature Reviews Gastroenterology & Hepatology, 21(3), 198–215. https://doi.org/10.1038/s41575-023-00872-2

Frequently Asked Questions

AHPRA Disclaimer: This information is general in nature and should not replace individual medical advice. Always discuss your test results and health concerns with a registered healthcare practitioner.